Laparoscopic Approach to Pyogenic Liver Abscess
Laproscopic Managment of Pyogenic Liver Abscess
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Assess the efficacy and safety of laparoscopic management of liver abscess in achieving complete drainage and clinical recovery compared to conventional open or percutaneous methods, and to:
- 1.To evaluate postoperative complications and recurrence rates.
- 2.To compare hospital stay, recovery time, and overall morbidity.
- 3.To determine patient outcomes and cost-effectiveness of laparoscopic intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 26, 2025
December 1, 2025
11 months
November 20, 2025
December 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Major complication rate
Procedure-related complications (Clavien-Dindo ≥ III) within 30 days.
30 days
Abscess recurrence
Recurrence at the same or new site
6 months.
Secondary Outcomes (1)
Technical success
30days
Study Arms (1)
Laproscopic managment
EXPERIMENTALInterventions
Laparoscopic management uses minimally invasive trocar access with camera-guided drainage and debridement, allowing precise abscess evacuation, reduced tissue trauma, faster recovery, and lower postoperative pain compared with open surgery or percutaneous drainage used in other studies.
Eligibility Criteria
You may qualify if:
- Adults ≥18 years.
- Radiologically confirmed liver abscess (US/CT/MRI).
- Abscess requiring drainage ≥5 cm,
- Failed or contraindicated percutaneous drainage.
- Recurrence after percutaneous drainage.
You may not qualify if:
- Adults ≥18 years.
- Radiologically confirmed liver abscess (US/CT/MRI).
- Abscess requiring drainage ≥5 cm,
- Failed or contraindicated percutaneous drainage.
- Recurrence after percutaneous drainage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Ndong A, Tendeng JN, Diallo AC, Dieye A, Diao ML, Diallo S, Diop S, Diallo MK, Diedhiou M, Fall ML, Ma Nyemb PM, Konate I. Efficacy of laparoscopic surgery in the treatment of hepatic abscess: A systematic review and meta-analysis. Ann Med Surg (Lond). 2022 Jan 31;75:103308. doi: 10.1016/j.amsu.2022.103308. eCollection 2022 Mar.
PMID: 35198179RESULTTeresi JA, Yu X, Stewart AL, Hays RD. Guidelines for Designing and Evaluating Feasibility Pilot Studies. Med Care. 2022 Jan 1;60(1):95-103. doi: 10.1097/MLR.0000000000001664.
PMID: 34812790RESULTWhitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19.
PMID: 26092476RESULTJulious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287-291.
RESULTInternational Journal of Surgery. Laparoscopic Drainage of Pyogenic Liver Abscess: A Feasible Alternative. https://www.ijsurgery.com/index.php/isj/article/view/9473
RESULTBansal V, et al. Systematic Review of Laparoscopic Drainage of Liver Abscess. Cureus. 2022;14(2):e22045. https://pmc.ncbi.nlm.nih.gov/articles/PMC8850317
RESULTSaravanan R, et al. Comparative Study of Laparoscopic Versus Open Surgical Drainage in Pyogenic Liver Abscess. SAR J Surg. 2024. https://sarpublication.com/media/articles/SARJS_62_10-14.pdf
RESULTMedscape. Liver Abscess Treatment & Management. https://emedicine.medscape.com/article/188802-treatment
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 26, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
December 26, 2025
Record last verified: 2025-12